Emerging Mechanisms and Therapeutic Strategies in Dilated Cardiomyopathy

Area of Science:

• Cardiology
• Genetics
• Molecular Biology

Background:

• Dilated cardiomyopathy (DCM) is a major cause of heart failure and transplantation, with diverse causes.
• DCM is now understood as multifactorial, involving genetic predisposition and environmental "second hits."
• Clonal hematopoiesis of indeterminate potential is emerging as a key factor in inflammation-driven cardiac remodeling.

Purpose of the Study:

• To provide an updated overview of recent advances in DCM molecular mechanisms and diagnosis.
• To discuss the implications of these advances for current and emerging therapeutic strategies.

Main Methods:

• Review of recent scientific literature on DCM.
• Analysis of genetic and environmental factors contributing to DCM.
• Evaluation of novel therapeutic approaches for DCM.

Main Results:

• DCM pathogenesis involves complex interactions between genetic backgrounds and secondary modifiers like clonal hematopoiesis.
• These interactions amplify shared inflammatory pathways, leading to adverse cardiac remodeling.
• Mechanism-informed therapies are advancing personalized and stage-specific DCM management.

Conclusions:

• Understanding the multifactorial nature of DCM is crucial for diagnosis and treatment.
• Targeting specific molecular pathways offers new therapeutic avenues for DCM.
• Personalized and stage-specific management strategies are transforming DCM care.